Emergent BioSolutions Inc. is a company in the U.S. stock market and it is a holding in 64 U.S.-traded ETFs. EBS has around 7.5M shares in the U.S. ETF market. The largest ETF holder of EBS is the iShares Core S&P Small-Cap ETF (IJR), with approximately 2.71M shares. Investors may also find of interest that the ETF with the largest allocation to EBS stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 2.67%. On average, U.S. ETFs allocate 0.23% of EBS to their portfolios.
Additionally, EBS is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EBS as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.